Skip to main content
SpringerLink
Log in

TGA consultations for OTC NSAIDs and ibuprofen/paracetamol

  • News item
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. see Reactions 1624 p2; 803203993

  2. diclofenac, flurbiprofen, ketoprofen, naproxen, and mefenamic acid

References

  1. Therapeutic Goods Administration. Submissions and TGA response: Non-steroidal anti-inflammatory drugs: proposed additional advisory statement. Internet Document : 13 Feb 2017. Available from: URL: https://www.tga.gov.au/submissions-and-tga-response-non-steroidal-anti-inflammatory-drugs-proposed-additional-advisory-statement

  2. Therapeutic Goods Administration. Submissions and TGA response: paracetamol and ibuprofen: proposed additional advisory statement. Internet Document : 13 Feb 2017. Available from: URL: https://www.tga.gov.au/submissions-and-tga-response-paracetamol-and-ibuprofen-proposed-additional-advisory-statement

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

TGA consultations for OTC NSAIDs and ibuprofen/paracetamol. Reactions Weekly 1640, 5 (2017). https://doi.org/10.1007/s40278-017-26558-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-017-26558-9

Search

Navigation